H-GLY-GLY-PHE-OH CAS#: 6234-26-0; ChemWhat Code: 87189
Identification
Patent Information | ||
Patent ID | Title | Publication Date |
US5286637 | Biologically active drug polymer derivatives and method for preparing same | 1994 |
US4727061 | Pharmaceutical preparations having diuretic activity | 1988 |
Physical Data
Appearance | White powder |
Melting Point, °C |
222 – 223 |
228 – 230 |
Spectra
Description (NMR Spectroscopy) | Nucleus (NMR Spectroscopy) | Solvents (NMR Spectroscopy) | Temperature (NMR Spectroscopy), °C |
Chemical shifts, Spectrum | 1H | CD3OD | |
Chemical shifts, Spectrum | 13C | CD3OD | |
Spectrum | 1H | heavy water | |
Chemical shifts | 1H | D2O | 29.84 |
1H | D2O | 29.84 | |
Chemical shifts | 13C | D2O | 29.84 |
Chemical shifts | 1H | dimethylsulfoxide-d6 |
H-GLY-GLY-PHE-OH CAS#: 6234-26-0 NMR |
Description (UV/VIS Spectroscopy) | Solvent (UV/VIS Spectroscopy) | Comment (UV/VIS Spectroscopy) |
Spectrum | various solvent(s) | 250 – 267 nm |
Route of Synthesis (ROS)
Conditions | Yield |
ith sodium hydrogencarbonate In water; N,N-dimethyl-formamide at 0 – 20℃; Experimental Procedure 8 Step 8. Synthesis of Compound 89 To a stirred mixture of (2S)-2-[2-(2-aminoacetamido)acetamido]-3-phenylpropanoic acid (Compound 88, 2.00 g, 7.16 mmol, 1.00 equiv) and NaHCO3 (1.80 g, 21.41 mmol, 3.00 equiv) in FLO (40.00 mL) were added BOC2O (1.86 g, 8.52 mmol, 1.20 equiv) in DMF (40.00 mL) dropwise at 0°C. The resulting mixture was stirred for overnight at room temperature. LCMS indicated the reaction was completed. The reaction was quenched with water at room temperature. The resulting mixture was extracted with EtOEt (3 x 50 mL). The combined organic layers were washed with brine (50 mL), dried over anhydrous Na2SO4. After filtration, the filtrate was concentrated under reduced pressure. The residue was purified by reverse flash chromatography with the following conditions: column, C18 silica gel; mobile phase, ACN water(0.05% TFA), 5% to 60% gradient in 30 min; detector, UV 220 nm. This resulted in (2S)-2-(2-[2-[(tert-butoxycarbonyl)amino]acetamido]acetamido)-3-phenylpropanoic acid (Compound 89, 1.8 g, 60%) as a white semi-solid. LCMS (ESI,ms):380[M+H]+,324[M+H-56]+. 1HNMR:(300MHz, DMSO-d6) δ 8.17(d, J=8.1Hz, 1H), 7.93(t, J=5.7Hz, 1H), 7.31-7.20(m, 5H), 7.00(t, J =6.0Hz, 1H), 4.46-4.39(m, 1H),3.78-3.67(m, 2H), 3.56(d, J =5.7Hz, 2H), 3.09-3.02(m, 1H), 2.92-2.73(m, 1H), 1.39(s, 9H). | 60% |
With sodium hydroxide In tetrahydrofuran for 3h; Ambient temperature; | |
With sodium hydrogencarbonate In water; N,N-dimethyl-formamide at 0 – 20℃; Inert atmosphere; | 1.8g |
Safety and Hazards
GHS Hazard Statements | Not Classified |
Source: European Chemicals Agency (ECHA)
License Note: Use of the information, documents and data from the ECHA website is subject to the terms and conditions of this Legal Notice, and subject to other binding limitations provided for under applicable law, the information, documents and data made available on the ECHA website may be reproduced, distributed and/or used, totally or in part, for non-commercial purposes provided that ECHA is acknowledged as the source: “Source: European Chemicals Agency, http://echa.europa.eu/”. Such acknowledgement must be included in each copy of the material. ECHA permits and encourages organisations and individuals to create links to the ECHA website under the following cumulative conditions: Links can only be made to webpages that provide a link to the Legal Notice page.
License URL: https://echa.europa.eu/web/guest/legal-notice
Record Name: (1-Cyano-2-ethoxy-2-oxoethylidenaminooxy)dimethylamino-morpholino-carbenium hexafluorophosphate
URL: https://echa.europa.eu/information-on-chemicals/cl-inventory-database/-/discli/details/213446
Description: The information provided here is aggregated from the “Notified classification and labelling” from ECHA’s C&L Inventory. Read more: https://echa.europa.eu/information-on-chemicals/cl-inventory-database
Other Data
HS Code | |
Storage | Store at 2–8°C, under vacuum for long time |
Shelf Life | 1 year |
Market Price |
Druglikeness | |
Lipinski rules component | |
Molecular Weight | 279.296 |
logP | -3.035 |
HBA | 7 |
HBD | 4 |
Matching Lipinski Rules | 4 |
Veber rules component | |
Polar Surface Area (PSA) | 121.52 |
Rotatable Bond (RotB) | 9 |
Matching Veber Rules | 2 |
Use Pattern |
It is a tripeptide consisting of glycine, glycine, and phenylalanine, with the sequence Gly-Gly-Phe. It has several noteworthy properties and potential uses, particularly in the field of peptide drug development. This tripeptide is commonly studied as a fragment of larger peptide drugs. It serves as a modular building block for synthesizing biologically active peptides with therapeutic applications. |
Buy Reagent | |
No reagent supplier? | Send quick inquiry to ChemWhat |
Want to be listed here as a reagent supplier? (Paid service) | Click here to contact ChemWhat |
Approved Manufacturers | |
Want to be listed as an approved manufacturer (Requires approvement)? | Please download and fill out this form and send back to approved-manufacturers@chemwhat.com |
Contact Us for Other Help | |
Contact us for other information or services | Click here to contact ChemWhat |